ZINECARD

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug ZINECARD contains one active pharmaceutical ingredient (API):

1	Dexrazoxane UNII 5346058Q7S - DEXRAZOXANE HYDROCHLORIDE
	Dexrazoxane has two major mechanisms of action, chelation of iron and inhibition of topoisomerase II. It is not known to what extent each of these mechanisms contributes to the preventive effect on tissue destruction following anthracycline extravasation.
	Read more about Dexrazoxane

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZINECARD Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AF02	Dexrazoxane	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02153432
US	FDA, National Drug Code	0013-8717